المؤلفون: Penn-Nicholson, A, Mbandi, SK, Thompson, E, Mendelsohn, SC, Suliman, S, Chegou, NN, Malherbe, ST, Darboe, F, Erasmus, M, Hanekom, WA, Bilek, N, Fisher, M, Kaufmann, SHE, Winter, J, Murphy, M, Wood, R, Morrow, C, Van Rhijn, I, Moody, B, Murray, M, Andrade, BB, Sterling, TR, Sutherland, J, Naidoo, K, Padayatchi, N, Walzl, G, Hatherill, M, Zak, D, Scriba, TJ, Kafaar, F, Workman, L, Mulenga, H, Hughes, EJ, Xasa, O, Veldsman, A, Cloete, Y, Abrahams, D, Moyo, S, Gelderbloem, S, Tameris, M, Geldenhuys, H, Ehrlich, R, Verver, S, Geiter, L, Black, GF, van der Spuy, G, Stanley, K, Kriel, M, Du Plessis, N, Nene, N, Roberts, T, Kleynhans, L, Gutschmidt, A, Smith, B, Loxton, AG, Tromp, G, Tabb, D, Ottenhoff, THM, Klein, MR, Haks, MC, Franken, KLMC, Geluk, A, van Meijgaarden, KE, Joosten, SA, Boom, WH, Thiel, B, Mayanja-Kizza, H, Joloba, M, Zalwango, S, Nsereko, M, Okwera, B, Kisingo, H, Parida, SK, Golinski, R, Maertzdorf, J, Weiner, J, Jacobson, M, Dockrell, H, Smith, S, Gorak-Stolinska, P, Hur, YG, Lalor, M, Lee, JS, Crampin, AC, French, N, Ngwira, B, Ben-Smith, A, Watkins, K, Ambrose, L, Simukonda, F, Mvula, H, Chilongo, F, Saul, J, Branson, K, Mahomed, H, Downing, K

المساهمون: The Adolescent Cohort Study team, The GC6-74 Consortium, The SATVI Clinical and Laboratory Team, The ScreenTB Consortium, The AE-TBC Consortium, The RePORT Brazil Team, Peruvian Household Contacts Cohort Team, The CAPRISA IMPRESS team, APH - Methodology, APH - Global Health, AII - Amsterdam institute for Infection and Immunity, Global Health, AII - Infectious diseases, Translational Immunology Groningen (TRIGR)

المصدر: Scientific reports
Scientific reports, vol 10, iss 1
Scientific Reports
Scientific reports, 10(1):8629. Nature Publishing Group
Scientific Reports, Vol 10, Iss 1, Pp 1-21 (2020)
Scientific Reports, 10(1). NATURE PUBLISHING GROUP
Scientific Reports, 10(1). NLM (Medline)
Scientific Reports, 10(1):8629. Nature Publishing Group

مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, GC6-74 Consortium, AE-TBC Consortium, lcsh:Medicine, HIV Infections, Disease, Biomarkers/metabolism, Lung/diagnostic imaging, ScreenTB Consortium, Cohort Studies, Prognostic markers, 0302 clinical medicine, Immunopathology, Peruvian Household Contacts Cohort Team, CAPRISA IMPRESS team, 030212 general & internal medicine, lcsh:Science, Lung, Subclinical infection, screening and diagnosis, RNA, Bacterial/metabolism, Multidisciplinary, Bacterial/metabolism, Bacterial, Prognosis, Tuberculosis/complications, RNA, Bacterial, Detection, Infectious Diseases, Mycobacterium tuberculosis/genetics, Area Under Curve, Cohort, Biomarker (medicine), HIV/AIDS, Female, Adolescent Cohort Study team, Infection, Cohort study, 4.2 Evaluation of markers and technologies, RePORT Brazil Team, medicine.medical_specialty, Tuberculosis, Adolescent, Point-of-Care Systems, HIV Infections/complications, Real-Time Polymerase Chain Reaction/methods, Real-Time Polymerase Chain Reaction, Sensitivity and Specificity, Article, 03 medical and health sciences, Rare Diseases, Tuberculosis diagnosis, Clinical Research, Internal medicine, medicine, Humans, business.industry, SATVI Clinical and Laboratory Team, Prevention, lcsh:R, Diagnostic markers, Mycobacterium tuberculosis, medicine.disease, 4.1 Discovery and preclinical testing of markers and technologies, 030104 developmental biology, Good Health and Well Being, ROC Curve, Positron-Emission Tomography, RNA, lcsh:Q, business, Biomarkers

وصف الملف: application/pdf; Electronic

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b72b4b335a138b78e75f4f968504b069
https://researchonline.lshtm.ac.uk/id/eprint/4656993/1/s41598-020-65043-8.pdf

المؤلفون: Mendelsohn, SC

المصدر: African Journal of Health Professions Education; Vol 6, No 1 (2014); 28-32

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=78975075580c::0574d4afd7c47822dca628e3dbc99a74
https://www.ajol.info/index.php/ajhpe/article/view/104922

المؤلفون: Muwanga VM; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa., Mendelsohn SC; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa., Leukes V; Division of Immunology, Faculty of Medicine and Health Sciences, DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research; South African Medical Research Council Centre for Tuberculosis Research; Stellenbosch University, Cape Town, South Africa., Stanley K; Division of Immunology, Faculty of Medicine and Health Sciences, DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research; South African Medical Research Council Centre for Tuberculosis Research; Stellenbosch University, Cape Town, South Africa., Mbandi SK; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa., Erasmus M; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa., Flinn M; Division of Immunology, Faculty of Medicine and Health Sciences, DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research; South African Medical Research Council Centre for Tuberculosis Research; Stellenbosch University, Cape Town, South Africa., Fisher TL; Division of Immunology, Faculty of Medicine and Health Sciences, DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research; South African Medical Research Council Centre for Tuberculosis Research; Stellenbosch University, Cape Town, South Africa., Raphela R; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa., Bilek N; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa., Malherbe ST; Division of Immunology, Faculty of Medicine and Health Sciences, DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research; South African Medical Research Council Centre for Tuberculosis Research; Stellenbosch University, Cape Town, South Africa., Tromp G; Division of Immunology, Faculty of Medicine and Health Sciences, DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research; South African Medical Research Council Centre for Tuberculosis Research; Stellenbosch University, Cape Town, South Africa., Van Der Spuy G; Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research; South African Medical Research Council Centre for Tuberculosis Research; Stellenbosch University, Cape Town, South Africa., Walzl G; Division of Immunology, Faculty of Medicine and Health Sciences, DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research; South African Medical Research Council Centre for Tuberculosis Research; Stellenbosch University, Cape Town, South Africa., Chegou NN; Division of Immunology, Faculty of Medicine and Health Sciences, DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research; South African Medical Research Council Centre for Tuberculosis Research; Stellenbosch University, Cape Town, South Africa., Scriba TJ; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa thomas.scriba@uct.ac.za.

مؤلفون مشاركون: AE-TBC and ScreenTB Consortium

المصدر: The European respiratory journal [Eur Respir J] 2024 Jul 04. Date of Electronic Publication: 2024 Jul 04.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: European Respiratory Society Country of Publication: England NLM ID: 8803460 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1399-3003 (Electronic) Linking ISSN: 09031936 NLM ISO Abbreviation: Eur Respir J Subsets: MEDLINE

المؤلفون: Mendelsohn SC; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Anzio Road, Observatory, 7935, Cape Town, South Africa., Andrade BB; Laboratório de Pesquisa Clínica e Translacional, Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Bahia 40296-710, Brazil., Mbandi SK; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Anzio Road, Observatory, 7935, Cape Town, South Africa., Andrade AMS; Laboratório de Pesquisa Clínica e Translacional, Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Bahia 40296-710, Brazil., Muwanga VM; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Anzio Road, Observatory, 7935, Cape Town, South Africa., Figueiredo MC; Vanderbilt University Medical Center, Nashville, TN 37232, USA., Erasmus M; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Anzio Road, Observatory, 7935, Cape Town, South Africa., Rolla VC; Laboratorio de Pesquisa Clinica em Micobacterioses, Instituto Nacional de Infectologia Evandro Chagas, Fiocruz, Rio de Janeiro 21040-360, Brazil., Thami PK; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Anzio Road, Observatory, 7935, Cape Town, South Africa., Cordeiro-Santos M; Fundação de Medicina Tropical Doutor Heitor Vieira Dourado., Penn-Nicholson A; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Anzio Road, Observatory, 7935, Cape Town, South Africa.; FIND, 9 Chemin des Mines, 1202, Geneva, Switzerland., Kritski AL; Universidade Federal do Rio de Janeiro, Rua Prof Rodolpho Paulo Rocco, 255, Centro de Pesquisa em Tuberculose, Cidade Universitária, 21941-913, Rio de Janeiro, RJ, Brazil., Hatherill M; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Anzio Road, Observatory, 7935, Cape Town, South Africa., Sterling TR; Vanderbilt University Medical Center, Nashville, TN 37232, USA., Scriba TJ; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Anzio Road, Observatory, 7935, Cape Town, South Africa.

مؤلفون مشاركون: RePORT-South Africa and RePORT-Brazil Consortia

المصدر: The Journal of infectious diseases [J Infect Dis] 2024 May 06. Date of Electronic Publication: 2024 May 06.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1537-6613 (Electronic) Linking ISSN: 00221899 NLM ISO Abbreviation: J Infect Dis Subsets: MEDLINE

المؤلفون: Mendelsohn SC; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, Western Cape, 7935, South Africa., Verhage S; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, Western Cape, 7935, South Africa., Mulenga H; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, Western Cape, 7935, South Africa., Scriba TJ; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, Western Cape, 7935, South Africa., Hatherill M; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, Western Cape, 7935, South Africa.

المصدر: Gates open research [Gates Open Res] 2023 May 05; Vol. 7, pp. 27. Date of Electronic Publication: 2023 May 05 (Print Publication: 2023).

نوع المنشور: Systematic Review

بيانات الدورية: Publisher: Bill and Melinda Gates Foundation Country of Publication: United States NLM ID: 101717821 Publication Model: eCollection Cited Medium: Internet ISSN: 2572-4754 (Electronic) Linking ISSN: 25724754 NLM ISO Abbreviation: Gates Open Res Subsets: PubMed not MEDLINE

المؤلفون: Spracklen TF; Department of Paediatrics and Child Health, University of Cape Town, Cape Town, South Africa.; Cape Heart Institute, University of Cape Town, Cape Town, South Africa., Mendelsohn SC; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa., Butters C; Department of Paediatrics and Child Health, University of Cape Town, Cape Town, South Africa.; Division of Immunology, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa., Facey-Thomas H; Department of Paediatrics and Child Health, University of Cape Town, Cape Town, South Africa., Stander R; Department of Paediatrics and Child Health, University of Cape Town, Cape Town, South Africa., Abrahams D; Department of Paediatrics and Child Health, University of Cape Town, Cape Town, South Africa., Erasmus M; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa., Baguma R; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa., Day J; Department of Paediatrics and Child Health, University of Cape Town, Cape Town, South Africa., Scott C; Department of Paediatrics and Child Health, University of Cape Town, Cape Town, South Africa., Zühlke LJ; Department of Paediatrics and Child Health, University of Cape Town, Cape Town, South Africa.; Cape Heart Institute, University of Cape Town, Cape Town, South Africa.; South African Medical Research Council, Cape Town, South Africa., Kassiotis G; Retroviral Immunology Laboratory, The Francis Crick Institute, London, United Kingdom.; Department of Infectious Disease, St Mary's Hospital, Imperial College, London, United Kingdom., Scriba TJ; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa., Webb K; Department of Paediatrics and Child Health, University of Cape Town, Cape Town, South Africa.; Crick African Network, The Francis Crick Institute, London, United Kingdom.

المصدر: Frontiers in immunology [Front Immunol] 2022 Sep 06; Vol. 13, pp. 992022. Date of Electronic Publication: 2022 Sep 06 (Print Publication: 2022).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

مواضيع طبية MeSH: COVID-19*/complications , COVID-19*/genetics , Interleukin-27*, Antiviral Agents ; Child ; Cytokines ; Gene Expression ; Humans ; Interleukin-1 ; SARS-CoV-2 ; South Africa ; Systemic Inflammatory Response Syndrome

SCR Disease Name: pediatric multisystem inflammatory disease, COVID-19 related

المؤلفون: Valinetz ED; Department of Medicine, University of Washington, Seattle, Washington.; Division of Infectious Disease, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA., Matemo D; Department of Research and Programs, Kenyatta National Hospital, Nairobi.; School of Public Health and Community Development Maseno University, Kisumu, Kenya., Gersh JK; Department of Medicine, University of Washington, Seattle, Washington., Joudeh LL; Department of Medicine, University of Washington, Seattle, Washington., Mendelsohn SC; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, and Division of Immunology, Department of Pathology, University of Cape Town, South Africa., Scriba TJ; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, and Division of Immunology, Department of Pathology, University of Cape Town, South Africa., Hatherill M; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, and Division of Immunology, Department of Pathology, University of Cape Town, South Africa., Kinuthia J; Department of Research and Programs, Kenyatta National Hospital, Nairobi.; Department of Global Health., Wald A; Department of Medicine, University of Washington, Seattle, Washington.; Department of Epidemiology.; Department of Lab Medicine & Pathology, University of Washington.; Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, Washington., Cangelosi GA; Department of Environmental and Occupational Health Sciences., Barnabas RV; Department of Medicine, University of Washington, Seattle, Washington.; Department of Global Health.; Department of Epidemiology., Hawn TR; Department of Medicine, University of Washington, Seattle, Washington., Horne DJ; Department of Medicine, University of Washington, Seattle, Washington.

المصدر: AIDS (London, England) [AIDS] 2022 Aug 01; Vol. 36 (10), pp. 1363-1371. Date of Electronic Publication: 2022 May 25.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 8710219 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1473-5571 (Electronic) Linking ISSN: 02699370 NLM ISO Abbreviation: AIDS Subsets: MEDLINE

مواضيع طبية MeSH: HIV Infections*/complications , HIV Infections*/drug therapy , Tuberculosis*/complications, Adult ; Antitubercular Agents/therapeutic use ; Cross-Sectional Studies ; Humans ; Isoniazid/therapeutic use

المؤلفون: Bender Ignacio RA; Department of Medicine, University of Washington, Seattle, WA, United States of America.; Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America., Long J; Department of Medicine, University of Washington, Seattle, WA, United States of America., Saha A; Department of Medicine, University of Washington, Seattle, WA, United States of America., Nguyen FK; Department of Medicine, University of Washington, Seattle, WA, United States of America., Joudeh L; Department of Medicine, University of Washington, Seattle, WA, United States of America., Valinetz E; Department of Medicine, University of Washington, Seattle, WA, United States of America., Mendelsohn SC; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa., Scriba TJ; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa., Hatherill M; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa., Janes H; Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America., Churchyard G; Aurum Institute, Parktown, South Africa.; School of Public Health, University of Witwatersrand, Johannesburg, South Africa.; Department of Medicine, Vanderbilt University, Nashville, TN, United States of America., Buchbinder S; San Francisco Department of Public Health and Departments of Medicine and Epidemiology, University of California San Francisco, San Francisco, CA, United States of America., Duerr A; Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America., Shah JA; Department of Medicine, University of Washington, Seattle, WA, United States of America.; Veteran Affairs Puget Sound Healthcare System, Seattle, WA, United States of America., Hawn TR; Department of Medicine, University of Washington, Seattle, WA, United States of America.

المصدر: PloS one [PLoS One] 2022 May 03; Vol. 17 (5), pp. e0267729. Date of Electronic Publication: 2022 May 03 (Print Publication: 2022).

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

مواضيع طبية MeSH: HIV Infections*/complications , Latent Tuberculosis* , Mycobacterium tuberculosis* , Tuberculosis*/complications, Antigens, Bacterial ; CD4-Positive T-Lymphocytes ; Case-Control Studies ; Humans

المؤلفون: Mulenga H; South African Tuberculosis Vaccine Initiative, Department of Pathology, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, University of Cape Town, Anzio Road, Observatory 7925, South Africa., Fiore-Gartland A; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Fairview Ave. N., Seattle, WA 98109-1024, USA., Mendelsohn SC; South African Tuberculosis Vaccine Initiative, Department of Pathology, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, University of Cape Town, Anzio Road, Observatory 7925, South Africa., Penn-Nicholson A; South African Tuberculosis Vaccine Initiative, Department of Pathology, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, University of Cape Town, Anzio Road, Observatory 7925, South Africa., Mbandi SK; South African Tuberculosis Vaccine Initiative, Department of Pathology, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, University of Cape Town, Anzio Road, Observatory 7925, South Africa., Nemes E; South African Tuberculosis Vaccine Initiative, Department of Pathology, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, University of Cape Town, Anzio Road, Observatory 7925, South Africa., Borate B; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Fairview Ave. N., Seattle, WA 98109-1024, USA., Musvosvi M; South African Tuberculosis Vaccine Initiative, Department of Pathology, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, University of Cape Town, Anzio Road, Observatory 7925, South Africa., Tameris M; South African Tuberculosis Vaccine Initiative, Department of Pathology, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, University of Cape Town, Anzio Road, Observatory 7925, South Africa., Walzl G; DST/NRF Centre of Excellence for Biomedical TB Research and SAMRC Centre for TB Research, Division of Molecular Biology and Human Genetics, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Stellenbosch University, Francie Van Zijl Drive, Parow 7505, South Africa., Naidoo K; Centre for the AIDS Programme of Research in South Africa (CAPRISA), Doris Duke Medical Research Institute, University of KwaZulu-Natal, 719 Umbilo Road, Durban 4001, South Africa.; MRC-CAPRISA HIV-TB Pathogenesis and Treatment Research Unit, Doris Duke Medical Research Institute, University of KwaZulu-Natal, 719 Umbilo Road, Durban 4001, South Africa., Churchyard G; The Aurum Institute, 29 Queens Rd, Parktown, Johannesburg, Gauteng 2194, South Africa.; School of Public Health, University of Witwatersrand, 27 St Andrews Road, Parktown, Johannesburg 2193, South Africa.; Department of Medicine, Vanderbilt University, Nashville, TN, USA., Scriba TJ; South African Tuberculosis Vaccine Initiative, Department of Pathology, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, University of Cape Town, Anzio Road, Observatory 7925, South Africa., Hatherill M; South African Tuberculosis Vaccine Initiative, Department of Pathology, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, University of Cape Town, Anzio Road, Observatory 7925, South Africa.

مؤلفون مشاركون: CORTIS Study Team

المصدر: EClinicalMedicine [EClinicalMedicine] 2022 Apr 21; Vol. 47, pp. 101396. Date of Electronic Publication: 2022 Apr 21 (Print Publication: 2022).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: The Lancet Country of Publication: England NLM ID: 101733727 Publication Model: eCollection Cited Medium: Internet ISSN: 2589-5370 (Electronic) Linking ISSN: 25895370 NLM ISO Abbreviation: EClinicalMedicine Subsets: PubMed not MEDLINE

المؤلفون: Mendelsohn SC; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Anzio Road, Observatory, Cape Town 7925, South Africa., Fiore-Gartland A; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA., Awany D; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Anzio Road, Observatory, Cape Town 7925, South Africa., Mulenga H; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Anzio Road, Observatory, Cape Town 7925, South Africa., Mbandi SK; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Anzio Road, Observatory, Cape Town 7925, South Africa., Tameris M; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Anzio Road, Observatory, Cape Town 7925, South Africa., Walzl G; DST/NRF Centre of Excellence for Biomedical TB Research, South African Medical Research Council Centre for TB Research, Division of Molecular Biology and Human Genetics, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town 7505, South Africa., Naidoo K; Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban 4001, South Africa.; MRC-CAPRISA HIV-TB Pathogenesis and Treatment Research Unit, Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban 4001, South Africa., Churchyard G; The Aurum Institute, Johannesburg 2194, South Africa.; School of Public Health, University of Witwatersrand, Johannesburg 2193, South Africa.; Department of Medicine, Vanderbilt University, Nashville, TN 37232, USA., Scriba TJ; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Anzio Road, Observatory, Cape Town 7925, South Africa., Hatherill M; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Anzio Road, Observatory, Cape Town 7925, South Africa.

مؤلفون مشاركون: CORTIS-HR Study Team

المصدر: EClinicalMedicine [EClinicalMedicine] 2022 Mar 05; Vol. 45, pp. 101328. Date of Electronic Publication: 2022 Mar 05 (Print Publication: 2022).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: The Lancet Country of Publication: England NLM ID: 101733727 Publication Model: eCollection Cited Medium: Internet ISSN: 2589-5370 (Electronic) Linking ISSN: 25895370 NLM ISO Abbreviation: EClinicalMedicine Subsets: PubMed not MEDLINE